[ Price : $8.95]
Swedish researchers say they found no significant increase in the risk of death in patients who received paclitaxel-coated devices...[ Price : $8.95]
Stakeholders support an FDA recommendation to include premenopausal women in breast cancer drug development programs.[ Price : $8.95]
CBER director Peter Marks says FDA plans to warn patients whove had previous severe reactions after being vaccinated about such ri...[ Price : $8.95]
FDA expands its partnership with Palantir Technologies through a new $44.4 million three-year contract.[ Price : $8.95]
Federal Register notice: FDA releases a final guidance entitled Best Practices in Developing Proprietary Names for Human Prescript...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Best Practices in Developing Proprietary Names for Human No...[ Price : $8.95]
FDA accepts for priority review a Pfizer BLA for its 20-valent pneumococcal conjugate vaccine and its us for preventing invasive d...[ Price : $8.95]
FDA grants SoniVie a breakthrough device designation for the Tivus System for renal artery denervation and its use in treating res...